<VariationArchive RecordType="classified" VariationID="973257" VariationName="NM_024818.6(UBA5):c.160dup (p.Ser54fs)" VariationType="Duplication" Accession="VCV000973257" Version="5" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-10-15" DateCreated="2020-07-25" MostRecentSubmission="2020-07-25">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="961598" VariationID="973257">
      <GeneList>
        <Gene Symbol="LOC129937585" FullName="ATAC-STARR-seq lymphoblastoid active region 20539" GeneID="129937585" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="132660645" stop="132660924" display_start="132660645" display_stop="132660924" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="NPHP3-ACAD11" FullName="NPHP3-ACAD11 readthrough (NMD candidate)" GeneID="100532724" HGNC_ID="HGNC:48351" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="132558138" stop="132722459" display_start="132558138" display_stop="132722459" Strand="-" />
          </Location>
        </Gene>
        <Gene Symbol="UBA5" FullName="ubiquitin like modifier activating enzyme 5" GeneID="79876" HGNC_ID="HGNC:23230" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="132654430" stop="132679794" display_start="132654430" display_stop="132679794" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="132373289" stop="132396943" display_start="132373289" display_stop="132396943" Strand="+" />
          </Location>
          <OMIM>610552</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_024818.6(UBA5):c.160dup (p.Ser54fs)</Name>
      <CanonicalSPDI>NC_000003.12:132660696:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>3q22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="132660696" stop="132660697" display_start="132660696" display_stop="132660697" variantLength="1" positionVCF="132660696" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="132379540" stop="132379541" display_start="132379540" display_stop="132379541" variantLength="1" positionVCF="132379540" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <ProteinChange>S54fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_042830.1" sequenceAccession="NG_042830" sequenceVersion="1" change="g.4435dup">
            <Expression>NG_042830.1:g.4435dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_052968.1" sequenceAccession="NG_052968" sequenceVersion="1" change="g.11252dup">
            <Expression>NG_052968.1:g.11252dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001320210.2" sequenceAccession="NM_001320210" sequenceVersion="2" change="c.-359dup">
            <Expression>NM_001320210.2:c.-359dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001321238.2" sequenceAccession="NM_001321238" sequenceVersion="2" change="c.-325dup">
            <Expression>NM_001321238.2:c.-325dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001321239.1" sequenceAccession="NM_001321239" sequenceVersion="1" change="c.-41dup">
            <Expression>NM_001321239.1:c.-41dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_024818.6" sequenceAccession="NM_024818" sequenceVersion="6" change="c.160dup" MANESelect="true">
            <Expression>NM_024818.6:c.160dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_079094.1" sequenceAccession="NP_079094" sequenceVersion="1" change="p.Ser54fs">
            <Expression>NP_079094.1:p.Ser54fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_198329.4" sequenceAccession="NM_198329" sequenceVersion="4" change="c.-7-5126dup">
            <Expression>NM_198329.4:c.-7-5126dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.132379541dup" Assembly="GRCh37">
            <Expression>NC_000003.11:g.132379541dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.132660697dup" Assembly="GRCh38">
            <Expression>NC_000003.12:g.132660697dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1938110760" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_024818.6(UBA5):c.160dup (p.Ser54fs) AND Developmental and epileptic encephalopathy, 44" Accession="RCV001249672" Version="5">
        <ClassifiedConditionList TraitSetID="32656">
          <ClassifiedCondition DB="MedGen" ID="C4310700">Developmental and epileptic encephalopathy, 44</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-05-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-05-29" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-07-25" MostRecentSubmission="2020-07-25">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="32656" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36182" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Epileptic encephalopathy, early infantile, 44</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 44</ElementValue>
                <XRef ID="MONDO:0014933" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DEE44</ElementValue>
                <XRef Type="MIM" ID="617132" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16198" />
                <XRef ID="16198" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C4310700" DB="MedGen" />
              <XRef ID="MONDO:0014933" DB="MONDO" />
              <XRef Type="MIM" ID="617132" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2807057" SubmissionDate="2020-05-21" DateLastUpdated="2020-07-25" DateCreated="2020-07-25">
        <ClinVarSubmissionID localKey="NCH:2535|OMIM:617132" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001423623" DateUpdated="2020-07-25" DateCreated="2020-07-25" Type="SCV" Version="1" SubmitterName="Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital" OrgID="196472" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-05-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>[ACMG/AMP: PVS1, PM1, PM2, PP3] This alteration is a null variant in a gene where LOF is a known mechanism of disease [PVS1], is located in a mutational hotspot and/or critical and well-established functional domain [PM1], is absent from or rarely observed in large-scale population databases [PM2], is predicted to be damaging by multiple functional prediction tools [PP3].</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="UBA5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_024818.3:c.160dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="617132" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7483583</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2807057" TraitType="Disease" MappingType="XRef" MappingValue="617132" MappingRef="OMIM">
        <MedGen CUI="C4310700" Name="Developmental and epileptic encephalopathy, 44" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

